Alcohol-attributable cancer deaths in the U.S. doubled between 1990 and 2023, Sylvester-led study shows

Sylvester’s Marlon Wong receives Gabrielle’s Angel Foundation grant to study CIPN

Marlon L. Wong, associate professor of clinical physical therapy at the University of Miami Miller School of Medicine, was awarded a grant from Gabrielle’s Angel Foundation for Cancer Research. The three-year, $225,000 award will support research focused on improving quality of life for patients living with chemotherapy-induced peripheral neuropathy and other long-term effects of cancer treatment.

July 24, 2026

Vol.52 No.29

Clinical Roundup

Sylvester researchers discover method of disrupting inflammatory network that helps pancreatic cancer resist treatment

Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to a study led by researchers at Sylvester Comprehensive Cancer Center.

June 26, 2026

Vol.52 No.25

Clinical Roundup

DNA methylation is a key factor in predicting resistant tumors, Sylvester-led study suggests

Researchers have identified groups of patients with pleural mesothelioma, a rare and aggressive cancer, who are more likely to respond to immunotherapy, offering clues about why only some tumors respond to the treatment.

May 15, 2026

Vol.52 No.19

In Brief

Sylvester data portal combines multi-sourced clinical and genomic data into unified platform

Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has developed a cloud-based informatics platform that combines clinical and genomic data from multiple sources into one unified platform.

April 17, 2026

Vol.52 No.15

Beyond the lab: Engineering collaboration in modern cancer research

Cancer research increasingly demands environments that mirror the biology it seeks to understand: Complex, adaptive and deeply interconnected. At Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, collaboration is not treated as an optional cultural trait but as a structural requirement.

March 27, 2026

Vol.52 No.12

Clinical Roundup

“Lock-and-key” chemistry platform may keep therapeutic drugs inactive until they reach a tumor, Syracuse-led study finds

Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant side effects. This creates a critical need for strategies that localize their toxic activity to tumors. What if cancer drugs could stay dormant until they reach cancer cells? A study by Syracuse University researchers demonstrates a promising chemistry-based strategy that could do just that.

February 27, 2026

Vol.52 No.08

Alcohol-attributable cancer deaths in the U.S. doubled between 1990 and 2023, Sylvester-led study shows

YOU MAY BE INTERESTED IN

Sylvester’s Marlon Wong receives Gabrielle’s Angel Foundation grant to study CIPN

Sylvester researchers discover method of disrupting inflammatory network that helps pancreatic cancer resist treatment

DNA methylation is a key factor in predicting resistant tumors, Sylvester-led study suggests

Sylvester data portal combines multi-sourced clinical and genomic data into unified platform

Beyond the lab: Engineering collaboration in modern cancer research

“Lock-and-key” chemistry platform may keep therapeutic drugs inactive until they reach a tumor, Syracuse-led study finds

Renew today!

Subscriber content

Never miss an issue!

Login